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INTRODUCTION
Gene knockdown/knockout technology has contributed fundamentally to our understanding of the cellular functions of various genes. Knockdown is achieved by using siRNA that can be used transiently or shRNA that can also be stably expressed in target cells (1) (2) (3) . However, since these methods reduce, but do not eliminate the expression of target genes, the biological consequences on the affected cells are not always complete. Efficient elimination of gene expression is therefore required to obtain a comprehensive assessment of the cellular role of a given gene. Two main systems have manifested themselves as the leading technologies for achieving this goal. The first is the Cre-LoxP technology (4, 5) , and the second is the CRISPR-Cas9 system, which revolutionized genome editing capability (6) .
Cre is a 38-kDa site specific DNA recombinase that recognizes a 34-bp sequence denoted loxP, resulting in intra and inter molecular recombination between two loxP sites depending on their orientation and location (7) . The loxP sites, composed of an 8-bp non-palindromic core flanked by two 13-bp inverted repeats, are usually placed in the desired locations and orientations in the desired DNA sequence via homologous recombination using a construct containing selectable markers (8) .
When two LoxP sites flank a sequence and are directly repeated, Cre excises the entire DNA segment located between them.
endonuclease and helicase enzyme called Cas9, capable of cutting double stranded DNA at a specific genomic location, depending on the targeting sequence presented in the gRNA sequence. The single guide RNA is composed of 20 nucleotides, homologous to the genomic site to be edited, and an RNA scaffold portion that facilitates Cas9 binding to the DNA site to generate the doublestrand breaks (DSBs) at the target genomic site (9) (10) (11) . The DBSs are usually repaired by the NonHomologous End-Joining (NHEJ) pathway that frequently generates deletions or insertions, seldom resulting in abolishing the expression of the tested protein. Variants of Cas9 are still being developed to enhance specificity and minimize off-target editing (12) (13) (14) .
A less efficient, high fidelity repair pathway employed by cells is the Homology Directed Repair (HDR) pathway. This high fidelity repair pathway can be exploited by mutating Cas9 at one of its catalytic domains to create a nickase variant, termed Cas9 nickase, capable of generating single-stranded DNA breaks that together with a DNA "repair template", allow repair to proceed by HDR rather than NHEJ, leading to a more precise gene editing or to the addition of sequences to endogenous DNA, depending on the template used (15) . The process is limited by relatively low efficiency, and several methods have been developed in order to increase efficiency (16) but not without possible negative effects (17) .
While both methods are suitable for the investigation of many genes, inducible systems are required for the investigation of essential genes and for investigating the temporal importance of genes during development. To achieve inducibility, Cre is fused to a mutated hormone-binding domain of the estrogen receptor, generating a chimeric Cre recombinase, termed CreER, that is activated by synthetic estrogen receptor ligands (18) (19) (20) (21) . CRISPR-Cas9 inducible systems were also developed, which rely either on an inducible promoter or on the activation of a CRISPR-Cas9 estrogen receptor chimera (22) (23) (24) (25) . However, expression of Cas9 from inducible promoters can be leaky, (26) (27) , and the introduction of LoxP sites into a specific genomic location requires extensive constructions and manipulations, seldom with varying efficiencies (28) (29) (30) .
Here, we present a simple method that combines the CRISPR-Cas9 and the Cre-loxP systems. This method is particularly useful for the conditional deletion of essential genes in mammalian tissue cultured cells and can further be exploited to identify mutants of tested genes. pE-eIF5A1smut, containing a FLAG-tagged eIF5A1 that is refractory to the guide RNA, was constructed in two steps; first, eIF5A1 cDNA was amplified by PCR using a 5' primer containing a LoxP site and appending a FLAG tag to the N-terminus of eIF5A1 and a 3' primer containing a LoxP site. The resulting fragment was cloned into the bicistronic pEFIRES vector containing a selectable marker conferring puromycin resistance (Table 2) . Next, three silent mutations were introduced at the site of recognition by the guide RNA to make it refractory to editing by the CRISPR-Cas9 (Table 2) .
MATERIAL AND METHODS

Plasmid constructs
Wild type eIF5A1(pWT-5A1) and a K50R mutant (pK50R-5A1) that cannot undergo hypusination and harbouring mutations that makes them refractory to recognition by the gRNA were PCR amplified using eIF5A1 specific primers and cloned into a bicistronic pEFIRES vector harbouring a selectable marker conferring hygromycin resistance.
Cell culture
NIH3T3 mouse fibroblasts were grown in Dulbecco's modified Eagle's medium (Invitrogen)
supplemented with 10% (v/v) fetal bovine serum, 100 units/ml penicillin, and 100 μ g/ml streptomycin (Biological Industries).
NIH3T3 cells were transfected using Lipofectamine 2000 (Invitrogen) following the manufacturer's instructions. Twenty four hours post transfection the cells were split and subjected to the indicated selections. When validation of a successful knockout was required, individual foci were selected, expanded and subjected to western blot analysis using an anti eIF5A1 antibody. Positively identified clones were subjected to single cell cloning. mouse mAb anti-eIF5A1 (BD Transduction Laboratories, #611976), mAb anti-FLAG M2 (Sigma, # F1804). Signals were developed using "EZ-ECL" (Biological Industries), and the membranes were analysed using ImageQuant LAS4000 luminescent image analyser (General Electric).
Immunoblot Analysis
RESULTS
Establishment of a cell line expressing inducible Cre
The first step in the establishment of the inducible gene knockout system was the cloning of a variant of CreER (35) , and the resulting construct was transfected into NIH3T3 mouse fibroblasts. Since the second ORF of the bicistronic transcript encodes resistance to G418, the transfected cells were selected for growth in the presence of G418 (500ug/ml). G418 resistant cells were selected and tested for functionality and inducibility of the ER T2 CreER T2 by transient transfection with the Stoplight construct (36) , and induction using 4-Hydroxytamoxifen(4-OHT).
CRISPR-Cas9 mediated knockout
Following the establishment of cells stably expressing ER T2 CreER
T2
, we next set up to knockout the gene encoding eIF5A1 (37), using CRISPR-Cas9 (38). Deskgen's Guide Picker (39) was used to identify optimal target site. Oligonucleotides representing the single-guide RNA (sgRNA) were cloned in the pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid (40) . Since eIF5A1 is an essential gene (41), the resulting Cas9 construct was co-transfected into the ER T2 CreER T2 expressing NIH3T3 cells together with a bicistronic construct expressing a floxed, flag tagged eIF5A1 containing a silent mutation making it refractory to the guide RNA. The puromycin resistance encoded as a second ORF of the bicistronic transcript enabled the isolation of individual foci. Western blot analysis performed on cellular extracts prepared from cells representing individual foci identified clones that lost their endogenous eIF5A1 but express the FLAG-tagged eIF5A1 expressed from the floxed allele ( Figure  1A ).
Induction of Cre-mediated deletion of the ectopically expressed FLAG-tagged eIF5A1.
Since the FLAG-tagged eIF5A1 encoded from the bicistronic plasmid is also flanked with unidirectional loxP sequences, it can be deleted by activating the ER T2 CreER T2 encoded in these cells.
To induce deletion of the FLAG-tagged floxed eIF5A1 transgene, the cells were treated with 1µM 4-OHT. As can be seen in figure 1B , the levels of the FLAG-tagged eIF5A1 declined gradually, becoming very low already at day 2, almost undetected at day 3 and completely absent from day 4 and on. The depletion of eIF5A1 was accompanied by cessation of cellular proliferation noted between day 2 and 4 ( Figure 1C ).
Screening for mutant proteins
We next set out to test the possibility that the inducible knockout system we present here can also be used for screening for potential mutants of the tested proteins. For this purpose we cloned a wild-type (pWT-5A1) and a non-hypusinated mutant of eIF5A1 (pK50R-5A1) into a bicistronic vector encoding at its second ORF hygromycin resistance as a selectable marker. Hypusination is a unique post translational modification of eIF5A proteins demonstrated to be essential for their functionality (41) (42) (43) (44) ). An empty vector was used as negative control ( Figure 2B ). Following transfection, cells growing in the presence of hygromycin were selected and induced by the addition of 4-OHT to the growth medium. As expected, decline in the level of the FLAG-tagged eIF5A1 encoded by the floxed allele was observed, whereas the expressed wild type and non-hypusinated mutant remained unaffected ( Figure  2A) . Concomitantly, cells that were stably transfected with the wild-type encoding construct remained proliferating, while those transfected with an empty vector or with the vector encoding the nonhypusinated mutant became growth arrested ( Figure 2B ).
DISCUSSION
We present here a simple and efficient method that enables the generation of conditional knockouts of essential genes in mammalian cells (Figure 3 ). This method combines two highly efficient platforms, the CRISPR-Cas9 and the Cre-loxP systems. In this system, conditional knockout is manifested in two simple steps. In the first step, ER T2 CreER T2 is stably expressed in the target cells. This step can be performed as the starting point in any cell line before any downstream steps are taken. In the second step, two vectors are utilized simultaneously: a SpCas9 expressing vector with a gRNA designed to knockout the tested gene, and a bicistronic vector encoding a modified cDNA encoding a FLAG-tagged version of the protein encoded by the gene to be deleted. The cDNA is modified in two ways; it contains a silent mutation which makes it refractory to the CRISPR-Cas9 mediated DNA editing, and it is flanked by two LoxP sites added by PCR. The bicistronic transcript provides two functions. The puromycin resistance encoded by the second ORF enables the selection of foci, while the flag-tagged protein encoded by the first ORF provides a "back-up" that enables the deletion of the two genomic alleles encoding the essential protein. Successful deletion is verified by western blot analysis, relying on the size difference between the endogenous protein and the ectopically expressed FLAG-tagged protein, or by genomic analysis. ER T2 CreER T2 can then be activated by the addition of 4-OHT to the growth medium, resulting in the deletion of the ectopically expressed FLAGtagged protein, enabling the testing of the cellular role of the deleted protein.
Our method has several advantages compared to other methods of constructing inducible knockouts (45) (46) (47) . It is very simple and easy to be implemented since it is based on simple vectors without requiring complex genomic manipulation. The LoxP sites are introduced by simple PCR reaction into a plasmid without requiring their complicated introduction into the relevant genomic locus via homologous recombination. There is also no requirement for intermediate manipulation for the removal of the selectable marker used for the genomic introduction of the LoxP sites. The system is robust, tightly regulated and results in complete depletion of the tested protein. A further advantage is an additional layer of analysis that permits testing and screening potential mutants of the deleted protein, achieved by cloning cDNA encoding for specific mutants into a third bi-cistronic construct that provides resistance to hygromycin. Upon inducing deletion of the floxed supporting wild-type protein, the ability of the mutants to substitute the wild-type protein can be tested. This allows for a streamlined exploration of mutants, which can be further improved using a random barcoded library of mutants (48) (49) (50) . N  A  C  A  C  C  G  C  T  C  G  A  C  G  A  T  C  T  T  A  C  A  T  G  G  C   T  a  b  l  e  2  .  P  r  i  m  e  r  s  u  s  e  d  i  n  t  h  e  p  a  p  e  r   5  '  f  5  A  1  l  o  x  G  C  T  A  C  T  C  G  A  G  G  A  A  T  T  C  A  T  A  A  C  T  T  C  G  T  A  T  A  G  C  A  T  A  C  A  T  T  A  T  A  C  G  A  A  G  T  T  A  T  C  C  A  T  G  G  A  T  T  A  C  A  A  G  G  A  C  G  A  C  G  A  C  G  A  T  A  A  G  G  C  A  G  A  T  G  A   3  '  f  5  A  1  l  o  x  C  G  T  A  G  C  G  G  C  C  G  C  T  C  T  A  G  A  A  T  A  A  C  T  T  C  G  T  A  T  A  A  T  G  T  A  T  G  C  T  A  T  A  C  G  A  A  G  T  T  A  T  T  T  A  T  T  T  T  G  C  C  A  T  G  G  C  C  T  T  G  A  T  T  G  C  A  A  C  A  G  C  T  G   5  A  1  m  u  t  s  T  G  G  T  T  T  T  G  T  G  G  T  G  C  T  C  A  A  A  G  G  C  C  G  G  C  C  G  T  G  C  A  A  A  A  T  T  G  T  G  G  A  A  A  T  G  T  C  T  A  C  T  T  C  G  A  A  G  A  C  T  G  G  C  A  A  G  C  A   5  A  1  m  u  t  a  s  T  G  C  T  T  G  C  C  A  G  T  C  T  T  C  G  A  A  G  T  A  G  A  C  A  T  T  T  C  C  A  C  A  A  T  T  T  T 
